Diabetic Retinopathy Changes With Aflibercept, Bevacizumab, Ranibizumab
This cohort study compares changes in diabetic retinopathy severity after participants have received 1 and 2 years of treatment with aflibercept, bevacizumab, or ranibizumab.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research
More News: Avastin | Diabetes | Endocrinology | Lucentis | Opthalmology | Ranibizumab Injection | Study